Khloris Biosciences
Lynne A. Bui, MD is the Co-Founder, President, and CEO of Khloris Biosciences, Inc. She is a board-certified hematologist-oncologist, seasoned entrepreneur, angel investor, and drug developer, having unparalleled experience in basic, translational and clinical research spanning over 15 years with direct patient care and leading clinical development programs from preclinical IND enabling studies to Phase 1 to 3 registration studies for multiple approved drugs. She has held senior-level positions at Exelixis, Onyx, and Intelligence, and has experience with small molecules, antibodies, dendritic cell vaccines, gene therapies, embryonic stem cells, and cell therapies. She is also the Founder and Chairman of the Global Cancer Research Institute (GCRI) and GCRI Foundation. She received her M.D., internal medicine residency, and hematology/oncology fellowship training from the David Geffen UCLA School of Medicine, and her B.A. in molecular and cellular biology with an emphasis in neurobiology from UC Berkeley.
This person is not in any offices
Khloris Biosciences
Khloris Biosciences is a private biotechnology company located in the San Francisco Bay Area. They are dedicated to revolutionizing medical treatment and prevention of cancer and other diseases by harnessing the unlimited immunotherapeutic potential of induced pluripotent stem cells (iPSCs) for drug discovery, vaccine, and cell therapies.